Thomas A[au] - Search Results

Year	Number of Results
1858	1
1859	4
1860	2
1861	1
1866	1
1918	1
1931	1
1941	1
1942	1
1944	1
1945	1
1946	12
1947	10
1948	10
1949	4
1950	7
1951	8
1952	12
1953	11
1954	5
1955	5
1956	12
1957	7
1958	10
1959	6
1960	13
1961	11
1962	19
1963	13
1964	9
1965	9
1966	17
1967	17
1968	21
1969	15
1970	15
1971	9
1972	22
1973	23
1974	20
1975	19
1976	24
1977	31
1978	36
1979	32
1980	27
1981	32
1982	31
1983	32
1984	30
1985	36
1986	51
1987	38
1988	52
1989	42
1990	65
1991	58
1992	62
1993	54
1994	83
1995	105
1996	90
1997	87
1998	102
1999	98
2000	110
2001	117
2002	115
2003	133
2004	165
2005	156
2006	210
2007	221
2008	232
2009	304
2010	327
2011	308
2012	301
2013	354
2014	388
2015	414
2016	447
2017	409
2018	498
2019	504
2020	628
2021	671
2022	653
2023	265

1

An Evidence-Based Narrative Review of Mechanisms of Resistance Exercise-Induced Human Skeletal Muscle Hypertrophy.

Lim C, Nunes EA, Currier BS, McLeod JC, Thomas ACQ, Phillips SM. Lim C, et al. Among authors: thomas acq. Med Sci Sports Exerc. 2022 Sep 1;54(9):1546-1559. doi: 10.1249/MSS.0000000000002929. Epub 2022 Apr 6. Med Sci Sports Exerc. 2022. PMID: 35389932 Free PMC article. Review.

2

Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect.

Nishiga Y, Drainas AP, Baron M, Bhattacharya D, Barkal AA, Ahrari Y, Mancusi R, Ross JB, Takahashi N, Thomas A, Diehn M, Weissman IL, Graves EE, Sage J. Nishiga Y, et al. Among authors: thomas a. Nat Cancer. 2022 Nov;3(11):1351-1366. doi: 10.1038/s43018-022-00456-0. Epub 2022 Nov 21. Nat Cancer. 2022. PMID: 36411318 Free PMC article.

3

A tissue-like neurotransmitter sensor for the brain and gut.

Li J, Liu Y, Yuan L, Zhang B, Bishop ES, Wang K, Tang J, Zheng YQ, Xu W, Niu S, Beker L, Li TL, Chen G, Diyaolu M, Thomas AL, Mottini V, Tok JB, Dunn JCY, Cui B, Pașca SP, Cui Y, Habtezion A, Chen X, Bao Z. Li J, et al. Among authors: thomas al. Nature. 2022 Jun;606(7912):94-101. doi: 10.1038/s41586-022-04615-2. Epub 2022 Jun 1. Nature. 2022. PMID: 35650358 Free PMC article.

4

Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets.

Gao Y, Li D, Lin J, Thomas AM, Miao J, Chen D, Li S, Chu C. Gao Y, et al. Among authors: thomas am. Front Aging Neurosci. 2022 Aug 12;14:961661. doi: 10.3389/fnagi.2022.961661. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36034144 Free PMC article. Review.

5

Salter Harris Fractures.

Levine RH, Thomas A, Nezwek TA, Waseem M. Levine RH, et al. Among authors: thomas a. 2023 Jan 15. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. 2023 Jan 15. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 28613461 Free Books & Documents.

6

Type 3 autoimmune pancreatitis (immune checkpoint inhibitor-induced pancreatitis).

Sayed Ahmed A, Abreo M, Thomas A, Chari ST. Sayed Ahmed A, et al. Among authors: thomas a. Curr Opin Gastroenterol. 2022 Sep 1;38(5):516-520. doi: 10.1097/MOG.0000000000000873. Epub 2022 Jul 15. Curr Opin Gastroenterol. 2022. PMID: 35881977 Review.

7

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022.

Hause AM, Marquez P, Zhang B, Myers TR, Gee J, Su JR, Blanc PG, Thomas A, Thompson D, Shimabukuro TT, Shay DK. Hause AM, et al. Among authors: thomas a. MMWR Morb Mortal Wkly Rep. 2022 Nov 4;71(44):1401-1406. doi: 10.15585/mmwr.mm7144a3. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36327162 Free PMC article.

8

Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection.

Shatila M, Thomas AS. Shatila M, et al. Among authors: thomas as. J Clin Med. 2022 Aug 30;11(17):5086. doi: 10.3390/jcm11175086. J Clin Med. 2022. PMID: 36079015 Free PMC article. Review.

9

Short-term aerobic conditioning prior to resistance training augments muscle hypertrophy and satellite cell content in healthy young men and women.

Thomas ACQ, Brown A, Hatt AA, Manta K, Costa-Parke A, Kamal M, Joanisse S, McGlory C, Phillips SM, Kumbhare D, Parise G. Thomas ACQ, et al. FASEB J. 2022 Sep;36(9):e22500. doi: 10.1096/fj.202200398RR. FASEB J. 2022. PMID: 35971745

10

Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression.

Mao C, Yeh S, Fu J, Porosnicu M, Thomas A, Kucera GL, Votanopoulos KI, Tian S, Ming X. Mao C, et al. Among authors: thomas a. Sci Transl Med. 2022 Jun 8;14(648):eabh1261. doi: 10.1126/scitranslmed.abh1261. Epub 2022 Jun 8. Sci Transl Med. 2022. PMID: 35675434 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8,682 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8,682 results

Results by year